LDHA and nasopharyngeal carcinoma: Previous studies have reported that oxamate can inhibit LDH-A activity and CDX growth in nasopharyngeal carcinoma (30), and breast cancer (21) meanwhile enhances their sensitivity to radiotherapy or chemotherapy.